← Back to Search

Robotic Device

Robotic-assisted mini-Percutaneous Nephrolithotomy (PCNL) for Kidney Stones

N/A

Waitlist Available

Led By Jaime Landman, MD

Research Sponsored by Auris Health, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 30 days, post-operative (day 30)

Awards & highlights

Study Summary

This trial studies a robotic device for kidney stone removal. The data from this study will help improve the device and training for its use.

Eligible Conditions

Kidney Stones

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 30 days, post-operative (day 30)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 30 days, post-operative (day 30)

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 30 days, post-operative (day 30) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percentage of Robotic-assisted mini-Percutaneous Nephrolithotomy (PCNL) Procedures Completed

Secondary outcome measures

Number of Adverse Events

Number of Procedures Converted to Conventional Methods (Ureteroscopy or Percutaneous Nephrolithotomy)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Robotic-assisted mini-Percutaneous Nephrolithotomy (PCNL)Experimental Treatment1 Intervention

Participants with kidney stones will be enrolled for robotic-assisted mini-percutaneous nephrolithotomy procedure using the MONARCH Platform, Urology for removal of kidney stones. The MONARCH Platform, Urology enables electro-mechanical articulation and precise control of a flexible ureteroscope and/or a flexible mini-PCNL suction catheter for visualization and access to the urinary tract for diagnostic and therapeutic procedures.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Robotic-assisted mini-PCNL

2023

N/A

~20

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Auris Health, Inc.Lead Sponsor

5 Previous Clinical Trials

810 Total Patients Enrolled

Jaime Landman, MDPrincipal InvestigatorUniversity of California, Irvine

7 Previous Clinical Trials

1,005 Total Patients Enrolled

Media Library

MONARCH Platform, Urology (Robotic Device) Clinical Trial Eligibility Overview. Trial Name: NCT05835323 — N/A

Kidney Stones Research Study Groups: Robotic-assisted mini-Percutaneous Nephrolithotomy (PCNL)

Kidney Stones Clinical Trial 2023: MONARCH Platform, Urology Highlights & Side Effects. Trial Name: NCT05835323 — N/A

MONARCH Platform, Urology (Robotic Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05835323 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current sample size of this trial's participants?

"Affirmative. Clinical trials.gov reveals that this investigation is actively seeking participants, which was initially advertised on the 11th of January 2023 and last updated on April 18th 2023. It needs to recruit a total of twenty patients from one medical facility."

Answered by AI

Is it possible for participants to still join this investigation?

"As per information accessible on clinicaltrials.gov, this trial is still actively seeking suitable candidates to participate. The study was initially posted online on the 11th of January 2023 and had its most recent edit made on April 18th 2023."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Initial Clinical Experience With the MONARCH Platform, Urology for the Treatment of Kidney Stones

2023. "Initial Clinical Experience With the MONARCH Platform, Urology for the Treatment of Kidney Stones". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05835323.